Article

Blockade of Interleukin-6 (IL-6) Signaling in Dedifferentiated Liposarcoma (DDLPS) Decreases Mouse Double Minute 2 (MDM2) Oncogenicity via Alternative Splicing

2024-02-22

Abstract excerpt

Effective therapies for retroperitoneal (RP) dedifferentiated liposarcoma (DDLPS) remain unavailable. Loco-regional recurrence occurs in >80% of cases; 5-year disease-specific survival is only 20%. DDLPS is especially prevalent in the retroperitoneum and abdomen; evaluation of the DDLPS microenvironment in these high-fat compartments appears pertinent. Adipose is a main supplier of interleukin-6 (IL6); excessive a...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 5dd3ce36-4b43-580b-b811-2dedb4fa3075
DOI: 10.1101/2024.02.21.581397

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Blockade of Interleukin-6 (IL-6) Signaling in Dedifferentiated Liposarcoma (DDLPS) Decreases Mouse Double Minute 2 (MDM2) Oncogenicity via Alternative SplicingDOI 10.1101/2024.02.21.581397Read

Phenotypic transition in retroperitoneal liposarcoma: Bridging well-differentiated and dedifferentiated subtypes through genomics, epigenetics, and the tumor microenvironment.Semantic proximity Read

Dedifferentiated LiposarcomaSemantic proximity Read

Update on genomic and molecular landscapes of well-differentiated liposarcoma and dedifferentiated liposarcoma.Semantic proximity Read

Targeted transcriptomic analysis of well-differentiated and dedifferentiated liposarcoma reveals multiple dysregulated pathways including glucose metabolism, TGF-β, and HIF-1 signalingSemantic proximity Read

MDM2-p53 in liposarcoma: The need for targeted therapies with novel mechanisms of actionSemantic proximity Read

A metabolic crosstalk between liposarcoma and muscle sustains tumor growthSemantic proximity Read

The novel role of MDM2 in the diagnosis and treatment of dedifferentiated liposarcomaSemantic proximity Read

Extracellular Vesicle—MDM2-DNA as a Potential Liquid Biopsy Biomarker for Disease Identification in Retroperitoneal LiposarcomaSemantic proximity Read

A CRISPR-based <i>Xenopus tropicalis</i> model for retroperitoneal liposarcoma with genetic control over the dedifferentiation processSemantic proximity Read

Beyond targeting amplified MDM2 and CDK4 in well differentiated and dedifferentiated liposarcomas: From promise and clinical applications towards identification of progression driversSemantic proximity Read

Evaluation of well‐differentiated/de‐differentiated liposarcomas by high‐resolution oligonucleotide array‐based comparative genomic hybridizationSemantic proximity Read

Involvement of tumor suppressors PTEN and p53 in the formation of multiple subtypes of liposarcomaSemantic proximity Read